Eli Lilly Can't Escape Class Action Over Cymbalta Labeling
A California judge on Monday denied a bid by Eli Lilly & Co. to escape a proposed class action alleging inadequate labeling of the antidepressant Cymbalta, saying he could not decide...To view the full article, register now.
Already a subscriber? Click here to view full article